PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2011 2012
TB CARE I mechanism supports the National TB program (NTP) at all levels covering the whole country with estimated population of 40 million. The activities of the project are planned based on the NTP strategy for 2011-2015. The NTP is the leader of the planning exercise of the project together with the prime partner of TB CARE I, KNCV. The project is being used as an additional platform to coordinate the activities of other partners supporting the NTP through its partners' meetings. Contributions of other partners are considered during development of annual work plan of TB CARE I. The project ensures that the human resource capacity is maintained to the standard through trainings and supportive supervision. TB CARE I is planning to develop a workshop on sustainable financing of the TB control program to develop a sound exit strategy well before the project ends to ensure that gains made by USAID support are maintained.TB CARE-I reviews its activities quarterly and reports on its indicators, including TB/HIV, to its headquarters and to USAID using the NTP M&E framework.TB CARE-I has successfully implemented key activities set in the previous COP including assisting the NTP in hosting the second International Lung Health Conference, achieving 80% coverage of EQA and supervision, 70 % of specimen referral , introducing the first 3 GeneXpert machines to public access with 1000 cartilages, co-hosted Green Light Committee (GLC) and Global Drug Facility (GDF) missions with WHO & NTP, trained more than 400 health care workers and provided 6 short termTA. Lessons learned are considered in development of subsequent annual work plan focusing on maintaining the gains made so far. This activity supports GHI/LLC and is completely funded with pipeline funds in this budget cycle.
The main objective is assisting the National TB program (NTP) to maintain the case detection and treatment success rate, address MDR-TB challenges, enhance TB/HIV collaborative activities and contribute to health system strengthening.The overall implementation plan of TB CARE I/Kenya is mainly through financing core activities of the NTP at all levels along with short- and long-term TA. All the 12 TB control operational provinces benefit from USAID/TB CARE I assistance at all levels including 210 TB control operational districts. ATS and MSH are collaborating partners in the area of Stop TB Partnership, lab strengthening & universal access respectively. Local partners, Kenya AIDS NGO Consortium (KANCO) & Kenya Association for Prevention of TB and other Lung Diseases (KAPTLD), are sub-contracted through KNCV in engaging TB and TB/HIV patients and all TB/HIV care providers respectively. TB CARE-I works closely with the NTP by partially financing operations of the central unit, all provinces and districts to conduct regular supportive supervision, laboratory External Quality Assessment (EQA), MDR patient support, and review meetings. Most of the supports are complimentary to Global Fund grants, and TB CARE I annual plans consider contributions of other partners through consultation with the NTP, CDC, USAID mechanisms and other stakeholders.TB CARE I is supporting the NTP in the following thematic areas:1) Universal access: by engaging private health care providers, work places, civil society organizations, TB advocacy groups and others. Through the contribution of local partner (KAPTLD), private sector contribution reached 8% in 2010. 2) Lab strengthening: by providing short and long term TA and financial support to conduct regular EQA, specimen referral, introducing new technologies (e.g. GeneXpert), development of guidelines and training of lab staff. EQA coverage has reached 80% in 2011 from 46% in 2010 with improved quality indicators.3) Infection control: by developing training materials and conducting assessment to identify high risk health facilities for subsequent actions4) Program Management of MDR TB (PMDT): by providing patient support package for the needy patients, development of strategy, referral of sputum samples for culture and drug sensitivity tests (DST) from suspected MDR TB patients (e.g. retreatment cases). In 2011, about 160 MDR patients received patient support package. About 70% of retreatment cases sent their sputum sample to the central reference lab for culture and DST. About 300 health care workers were trained on PMDT in 2011 alone.5) TB/HIV collaboration: by supporting the NTP to develop IPT tools and sensitizing health workers on the tools. The private sector is engaged in TB/HIV collaborative activities through the support of the sub agreements.6) Health System Strengthening: TB CARE I is partly financing the core programmatic areas of the NTP to ensure routine supervision and TB program review at all level. TB CARE I is also assisting the NTP to be ISO certified to deliver quality service to its clients. Strengthening partnership is one of the key activities under this thematic area to leverage resource and maximize financing of TB control program. The district level supervision coverage has reached 80 % in 2011.7) M&E: by assisting the NTP to develop web based reporting using mobile and internet technology to allow transparent, accountable, reliable and effective TB program management.
